Korro Bio: RNA Editor Plots Way Back After AATD Study Fail - I'm Holding

KRRO-110 miss drives overhaul; KRRO-121/111 show preclinical promise. Click here to read my most recent analysis of the stock ...
Nasdaq

Altimmune's (ALT) Data From NASH Study Fail to Impress Investors

Shares of Altimmune ALT fell 27.04% during market hours on Sep 14, even after the company announced positive top-line results from its 12-week phase I study. The study evaluated pemvidutide in ...

Why Promising Lab Drugs Fail: Study Finds How Body Environment Can Flip Drug Effects

Findings published in the journal Nature Structural and Molecular Biology could help explain why drug candidates can look ...
Healthcare Dive

Rideshares fail to reduce patient no-show rates, study shows

A new study in JAMA Internal Medicine raises questions about the potential for rideshare-based nonemergency medical transportation programs to reduce missed medical appointments. In the study, ...
Beyond Pesticides

Study Finds Pesticide Product Labels Fail to Convey Toxic Effects to Consumers

To examine the efficacy of EPA’s label in conveying toxicity information to potential consumers, the researchers conduct an incentivized field experiment with eye tracking to evaluate the ...